Page 523 - Basic _ Clinical Pharmacology ( PDFDrive )

CHAPTER 28 Pharmacologic Management of Parkinsonism & Other Movement Disorders 509

PREP AR A TIONS Follett KA et al: Pallidal versus subthalamic deep-brain stimulation for Parkinson’s
disease. N Engl J Med 2010;362:2077.
A V AIL ABLE Fox SH et al: The Movement Disorders Society evidence-based medicine review
update: Treatments for the motor symptoms of Parkinson’s disease. Mov
Disord 2011;26(Suppl 3):S2.
GENERIC NAME AVAILABLE AS
Amantadine Generic, Symmetrel Garcia-Borreguero D et al: Treatment of restless legs syndrome with pregabalin: A
double-blind, placebo-controlled study. Neurology 2010;74:1897.
Apomorphine Apokyn Gottwald MD, Aminoff MJ: Therapies for dopaminergic-induced dyskinesias in
Benztropine Generic, Cogentin Parkinson disease. Ann Neurol 2011;69:919.
Biperiden Akineton Hartmann A, Worbe Y: Pharmacological treatment of Gilles de la Tourette syn-
drome. Neurosci Biobehav Rev 2013;37:1157.
Bromocriptine Generic, Parlodel Hauser RA et al: Extended-release carbidopa-levodopa (IPX066) compared with
Carbidopa Lodosyn immediate-release carbidopa-levodopa in patients with Parkinson’s disease
Carbidopa/levodopa Generic, Sinemet, Parcopa, Rytary and motor fluctuations; a phase 3 randomised, double-blind trial. Lancet
Carbidopa/levodopa/entacapone Generic, Stalevo Neurol 2013;12:346.
Entacapone Generic, Comtan Huster D: Wilson disease. Best Pract Res Clin Gastroenterol 2010;24:531.
Levodopa Dopar, others Jankovic J: Medical treatment of dystonia. Mov Disord 2013;28:1001.
Kalia LV, Kalia SK, Lang AE: Disease-modifying strategies for Parkinson’s disease.
Orphenadrine Generic, various Mov Disord 2015;30:1442.
Penicillamine Cuprimine, Depen Kimber TE: An update on Tourette syndrome. Curr Neurol Neurosci Rep
Pergolide * Permax, other 2010;10:286.
Pramipexole Generic, Mirapex Kordower JH et al: Transplanted dopaminergic neurons develop PD pathologic
changes: A second case report. Mov Disord 2008;23:2303.
Procyclidine Kemadrin LeWitt PA et al: AAV2-GAD gene therapy for advanced Parkinson’s disease: A
Rasagiline Azilect double-blind, sham-surgery controlled, randomised trial. Lancet Neurol
Ropinirole Generic, Requip, Requip XL 2011;10:309.
Safinamide Xadago Lorincz MT: Neurologic Wilson’s disease. Ann N Y Acad Sci 2010;1184:173.
Selegiline (deprenyl) Emsam Lyons KE, Pahwa R: Outcomes of rotigotine clinical trials: Effects on motor and
nonmotor symptoms of Parkinson’s disease. Neurol Clin 2013;31(3 Suppl):S51.
Tetrabenazine Xenazine Olanow CW et al: A double-blind, delayed-start trial of rasagiline in Parkinson’s
Tolcapone Tasmar disease. N Engl J Med 2009;361:1268.
Trientine Syprine Ondo W: Essential tremor: What we can learn from current pharmacotherapy.
Trihexyphenidyl Generic, Artane, others Tremor Other Hyperkinet Mov (NY) 2016;6:356.
Palfi S et al: Long-term safety and tolerability of ProSavin, a lentiviral vector-based
* Not available in the USA. gene therapy for Parkinson’s disease: A dose escalation, open-label, phase 1/2
trial. Lancet 2014;383:1138.
PD MED Collaborative Group: Long-term effectiveness of dopamine agonists
REFERENCES and monoamine oxidase B inhibitors compared with levodopa as initial
Angot E et al: Are synucleinopathies prion-like disorders? Lancet Neurol treatment for Parkinson’s disease (PD MED): A large, open-label, pragmatic
randomized trial. Lancet 2014;384:1196.
2010;9:1128. Perez-Lloret S et al: Adverse drug reactions to dopamine agonists: A com-
Antonini A et al: Role of pramipexole in the management of Parkinson’s disease. parative study in the French Pharmacovigilance Database. Mov Disord
CNS Drugs 2010;24:829. 2010;25:1876.
Bestha DP et al: Management of tics and Tourette’s disorder: An update. Expert Sadeghi R, Ondo WG: Pharmacological management of essential tremor. Drugs
Opin Pharmacother 2010;11:1813. 2010;70:2215.
Brewer GJ: The use of copper-lowering therapy with tetrathiomolybdate in medi- Schapira AH et al: Assessment of safety and efficacy of safinamide as a levodopa
cine. Expert Opin Investig Drugs 2009;18:89. adjunct in patients with Parkinson disease and motor fluctuations: A ran-
Bronstein JM et al: Deep brain stimulation for Parkinson disease: An expert con- domized clinical trial. JAMA Neurol 2017;74:216.
sensus and review of key issues. Arch Neurol 2010;68:165. Schilsky ML: Wilson disease: Current status and the future. Biochimie
Chang KH et al: Efficacy and safety of topiramate for essential tremor: 2009;91:1278.
A meta-analysis of randomized controlled trials. Medicine (Baltimore) Scott LJ: Gabapentin enacarbil: In patients with restless legs syndrome. CNS
2015;94:e1809. Drugs 2012;26:1073.
Cho HJ, Hallett M: Non-invasive brain stimulation for treatment of focal hand Seeberger LC, Hauser RA: Levodopa/carbidopa/entacapone in Parkinson’s disease.
dystonia: Update and future direction. J Mov Disord 2016;9:55. Expert Rev Neurother 2009;9:929.
Christine CW et al: Safety and tolerability of putaminal AADC gene therapy for Servello D et al: Deep brain stimulation in 18 patients with severe Gilles de la
Parkinson disease. Neurology 2009;73:1662. Tourette syndrome refractory to treatment: The surgery and stimulation. J
Connolly BS et al: Pharmacological treatment of Parkinson’s disease: A review. Neurol Neurosurg Psychiatry 2008;79:136.
JAMA 2014;311:1670. Simpson DM et al: Practice guideline update summary: Botulinum neurotoxin for
Cornelius JR et al: Impulse control disorders with the use of dopaminergic agents the treatment of blepharospasm, cervical dystonia, adult spasticity, and head-
in restless legs syndrome: A case control study. Sleep 2010;33:81. ache: Report of the Guideline Development Subcommittee of the American
Cummings J et al: Pimavanserin for patients with Parkinson’s disease psychosis: A Academy of Neurology. Neurology 2016;86:1818.
randomised, placebo-controlled phase 3 trial. Lancet 2014;383:533. Singer HS: Treatment of tics and Tourette syndrome. Curr Treat Options Neurol
David FJ et al: Exercise improves cognition in Parkinson’s disease: The PRET-PD 2010;12:539.
randomized, clinical trial. Mov Disord 2015;30:1657. Stocchi F et al: Initiating levodopa/carbidopa therapy with and without enta-
Earley CJ et al: Restless legs syndrome and periodic leg movements in sleep. Handb capone in early Parkinson disease: The STRIDE-PD study. Ann Neurol
Clin Neurol 2011;99:913. 2010;68:18.
Elias WJ et al: A pilot study of focused ultrasound thalamotomy for essential Tamara P et al: Tourette syndrome and other tic disorders of childhood. Handb
tremor. N Engl J Med 2013;369:640. Clin Neurol 2013;112:853.